Literature DB >> 3789138

Expression of a cholecystokinin precursor-related peptide in vertebrate and invertebrate tissues.

B S Schneider, J Maimon, J Friedman.   

Abstract

We have developed a radioimmunoassay for the nonapeptide predicted by cDNA sequence analysis to reside at the extreme C-terminus of the mouse cholecystokinin (CCK) precursor. Sensitivity of the assay is 1 pg synthetic CCK precursor-related peptide (CCK-PRP)/ml. The antibody has no cross-reactivity with cholecystokinin, gastrin, or a variety of other known neuropeptides. We have employed this assay to demonstrate the presence, in rodent brain, gut, and peripheral plasma, of peptides with immunological properties that are identical to, and gel filtration characteristics that are very similar to, those of the synthetic CCK-PRP. We have also detected a similar peptide in the culture media of a human CCK-producing tumor. The molar ratios of immunoreactive CCK-PRP/CCK vary widely among tissues of origin and during ontogeny, suggesting regional and developmental differences in the turnover rates or in posttranslational modification of the two peptides. Our studies suggest that peptides very similar to intact CCK-PRP are posttranslationally liberated from the cholecystokinin precursor in a variety of tissues and may have neurotransmitter and/or hormonal functions distinct from those of CCK. Relatively high quantities of material immunologically indistinguishable from CCK-PRP were also found in several coelenterate species, indicating that this epitope arose as early in evolution as did CCK.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789138     DOI: 10.1152/ajpendo.1986.251.6.E707

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  1 in total

1.  Expression of the cholecystokinin gene in pediatric tumors.

Authors:  J M Friedman; M Vitale; J Maimon; M A Israel; M E Horowitz; B S Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.